Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis PatientsLuka Verrest, Thomas P. C. Dorlo, Monique Wasunna et al.|Clinical Pharmacokinetics|2021Cited by 13
Anti-tubercular drug-induced hepatotoxicity in HIV-positive and negative patientsGetnet Yimer, Getachew Aderaye, Abraham Aseffa et al.|Toxicology Letters|2006Cited by 1
Distribution and concordance of phenotypically and genotypically determined acetylation status on patients taking anti-tuberculosis drugs in EthiopiaGetnet Yimer, Getachew Aderaye, Kidist Bobosha et al.|Toxicology Letters|2006Cited by 1